Replimune (REPL) Total Current Liabilities (2018 - 2026)
Replimune (REPL) posted Total Current Liabilities of $45.55 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 13.9% from $52.9 million a year earlier but up 18.6% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Total Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune's Total Current Liabilities came in at $58.23 million, down 6.6% from FY2025.
- Annual Total Current Liabilities shows a five-year compound annual growth rate of 32.0% (FY2021 to FY2026).
- In prior fiscal years, Replimune's Total Current Liabilities was $62.36 million in FY2025 (+54.2%), $40.44 million in FY2024 (+19.6%), $33.83 million in FY2023 (+63.0%) and $20.76 million in FY2022 (+42.7%).
- Quarterly Total Current Liabilities has run from a low of $18.29 million in fiscal Q3 2022 to a high of $62.36 million in fiscal Q4 2025 over five years.
- On a year-over-year basis, Total Current Liabilities has declined in each of the last three quarters, with growth averaging 14.3% over the last eight quarters.
- The strongest year-over-year quarter for Total Current Liabilities in the past five years was fiscal Q2 2024, with growth of 69.2%; the weakest was fiscal Q1 2027, with a decline of 35.5%.
- According to Business Quant data, Total Current Liabilities for the three prior fiscal quarters was $38.41 million (Q1 2027), $58.23 million (Q4 2026) and $50.09 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 47.00 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 55.46 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 43.10 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 28.80 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 23.23 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 12.00 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 31.73 Bn |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | 45.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 45.55 Mn |
| Jun 30, 2026 | 38.41 Mn |
| Mar 31, 2026 | 58.23 Mn |
| Dec 31, 2025 | 50.09 Mn |
| Sep 30, 2025 | 52.90 Mn |
| Jun 30, 2025 | 59.56 Mn |
| Mar 31, 2025 | 62.36 Mn |
| Dec 31, 2024 | 47.89 Mn |
| Sep 30, 2024 | 43.79 Mn |
| Jun 30, 2024 | 35.68 Mn |
| Mar 31, 2024 | 40.44 Mn |
| Dec 31, 2023 | 38.65 Mn |
| Sep 30, 2023 | 39.83 Mn |
| Jun 30, 2023 | 32.24 Mn |
| Mar 31, 2023 | 33.83 Mn |
| Dec 31, 2022 | 26.46 Mn |
| Sep 30, 2022 | 23.54 Mn |
| Jun 30, 2022 | 20.31 Mn |
| Mar 31, 2022 | 20.76 Mn |
| Dec 31, 2021 | 18.29 Mn |
API Access
Replimune Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();